Drug intelligence / Profile preview

Xiaoban tincture

Development stage: Unknown
Lead developer: First Affiliated Hospital of Guangzhou University of Chinese Medicine
Administration: Topical

Overview

Xiaoban tincture is a topical medication under investigation for the treatment of localized alopecia areata. It is applied to the affected area of the scalp, typically 1mL per application (approximately 7 sprays), and massaged for 3 to 5 minutes. The total daily dosage is less than 2 mL. It has been studied both as a standalone treatment and in combination with fire needle therapy. The specific active ingredients and detailed mechanism of action are not explicitly described in the provided context.

Other names: 消斑酊

Beyond the preview

Go deeper on Xiaoban tincture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaoban tincture.

Explore the full profile